Questcor Pharmaceuticals,
Inc., makes prescription drugs for the treatment of multiple sclerosis,
rheumatic disorders, and certain other illnesses and conditions.
My 5-year Yahoo chart for QCOR shows a robust up trend from
out of the market lows of 2009 until a
sudden and steep pullback in the second half of 2012.
Also,
my 3-month chart suggests strong gains for those who bought QCOR in the
second half of May 2013.
The 3-month chart suggests a continuation of the up trend at
least for now.
A
consensus of Yahoo’s stock analysts rates the stock as a strong buy.
Never
forget this: All investments and savings are gambles on the unknowable future
and thus subject to loss.
No comments:
Post a Comment